Ipamorelin

Ipamorelin is supplied as a catalogued research material in 5 mg and 10 mg.

Ipamorelin is a defined synthetic pentapeptide containing non-proteinogenic and D-configured residues. Registry values apply to the neutral structure shown; they must not be transferred to an unspecified acetate, trifluoroacetate or other salt.

Chemical properties and registry information

Registry values apply only to the specific molecular entity, sequence, termini and material form. Batch records take precedence over family-level literature identifiers.

Ipamorelin is a potent and selective growth hormone secretagogue that acts as a ghrelin receptor agonist. It stimulates GH release with minimal effect on prolactin or cortisol levels compared to other GHRPs.

Research background and published evidence

Published research

Ipamorelin has been studied in receptor and preclinical systems as a synthetic ligand associated with the growth-hormone secretagogue receptor pathway. Assay response depends on receptor expression, species, matrix and the exact chemical form.

Current scientific understanding

The available literature is predominantly mechanistic and preclinical and does not authenticate this batch. Findings for endogenous acyl-ghrelin or other secretagogue ligands cannot be transferred to ipamorelin.

Technical comparison

Quality and testing

Quality information is batch- and presentation-specific. Use only the report linked to the exact size and lot. A report listed for another size, lot or similarly named material must not be treated as evidence for this product.

Chromatographic area purity, identity, net peptide or analyte content, water or counter-ion content, sterility, endotoxin and elemental impurities are different measurements. One result does not establish the others. Only tests supported by a visible, matching report should be regarded as available.

Laboratory handling and storage

Store and handle only under the conditions stated on the product label, batch CoA and SDS. Keep the container secured, correctly identified and protected from contamination. Do not infer storage, solvent compatibility or stability from a related compound.

Laboratory preparation, analytical-method selection, risk assessment, personal protective equipment and waste disposal should follow the applicable SDS and the institution’s approved procedures.

Regulatory and legal status

Sources and references

1. [1] PubChem CID 9831659 — Ipamorelin
2. [2] European Journal of Endocrinology — pharmacological characterization of ipamorelin
3. [3] Science — discovery of the growth-hormone secretagogue receptor
4. [4] Nature — identification of ghrelin as an endogenous receptor ligand

Frequently Asked Questions

Do the CAS number and PubChem CID apply to every batch form?

Only when the exact sequence or structure, termini, conjugation, salt or counter-ion and hydration state match. The batch CoA and SDS govern; a related-compound identifier must not be substituted.

What does an analytical purity result mean?

It is method- and report-specific. For example, an HPLC area percentage is not automatically the same as identity, net content, sterility, endotoxin status or absence of elemental impurities.

How should the material be stored and handled?

Follow the exact label, batch CoA and SDS together with the institution’s risk assessment. Use only storage and stability information linked to the exact material form and batch.